Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212016
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209924
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210484
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209385
https://www.contractpharma.com/contents/view_breaking-news/2018-05-29/elite-pharma-glenmark-in-strategic-alliance/
https://www.bloomberg.com/news/articles/2018-04-24/shire-says-it-will-recommend-64-billion-revised-bid-from-takeda
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203600
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203600
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-13-2017-1513141175.pdf
https://globenewswire.com/news-release/2017/01/17/906224/0/en/Elite-Pharmaceuticals-Reports-Positive-Topline-Results-from-a-Pivotal-Bioequivalence-Study-for-a-Generic-OxyContin.html